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Abstract
Objective—To assess the causes for delay in the 
diagnosis o f homocystinuria.
Design—Clinical and laboratory data were col­
lected from patients diagnosed as having homo­
cystinuria due to cystathionine synthase deficiency, 
with special reference to the ages at which the 
patients had their first major signs of the disease, 
ectopia lends was established, and homocystinuria 
was diagnosed.
Setting—University hospital in the Netherlands.
Subjects—34 patients (18 males) in whom homo­
cystinuria due to cystathionine synthase deficiency 
was diagnosed in the period 1970-94.
Results—Among 34 consecutively detected 
homocystinuria patients the mean age at diag­
nosis o f homocystinuria was 24 (range 1-61) years. 
Despite frequent ocular manifestations, serious 
complications in the vascular, skeletal, and central 
nervous systems, and repeated examinations per­
formed in these patients by clinicians of various 
disciplines, there was a mean delay of 11 (0-43) 
years between the first major signs of the disease 
(at mean age 13 (1-40) years) and the ultimate 
diagnosis of homocystinuria. Even when ectopia 
lends was diagnosed (in 26 (76%) patients, mean 
age 18 (1-50) years), this did not lead to adequate 
biochemical analysis for homocystinuria at the 
time of detection, causing a mean diagnostic delay 
of 8 (0-24) years in these patients.
Conclusions—Three factors should have pre­
cipitated the diagnosis of homocystinuria: early 
recognition that unusual myopia (high, very high, 
abnormal p r o g r e ss iv e , or at young age) was 
caused by subluxation of the ocular lenses; aware­
ness that the occurrence of myopia combined with 
systemic complications (“myopia plus”) might be 
due to homocystinuria; and appropriate bio­
chemical investigations carried out in patients 
with ectopia lentis and in their siblings.
Introduction
Classic homocystinuria is an inborn error of metabo­
lism with autosomal recessive inheritance, characterised 
by the inability to convert methionine to cysteine due to 
a deficiency of cystathionine synthase (fig l ) .1 Accumu­
lation of homocysteine in tissues, blood, and urine is the 
consequence. Four major organ systems may be 
involved: the eye, the skeleton, the vascular system, and 
the central nervous system. Complications of the 
disease develop progressively if therapeutic measures 
have not been started at an early age,2 We have detected 
a large number of homocystinuria patients in adulthood 
by systematic biochemical screening of patients with 
one or more clinical signs of this disease. We analysed 
the causes of the delay in making the diagnosis of 
homocystinuria.
Subjects and methods
The study included 34 patients (18 males, 16 
females) in whom we established the diagnosis of homo­
cystinuria due to cystathionine synthase deficiency in 
the period from 1970 to 1994. Records of the patients, 
who had been referred for various reasons to the 
institute of ophthalmology or the institute of internal 
medicine at our hospital, were analysed with respect to 
the age at which the patients had their first major signs 
of the disease, the age at which ectopia lentis was estab­
lished, and the age at which homocystinuria was 
diagnosed. The time interval between these manifesta­
tions and the ultimate diagnosis of homocystinuria was 
calculated. The causes of delay in making the diagnosis 
of homocystinuria in these patients were studied from 
the records.
All patients underwent complete ophthalmological 
examination before and after maximal dilatation of the 
pupils, with special attention to the presence of ectopia 
lentis (subluxation or luxation of ocular lenses) and 
refractive error. Ophthalmic data before referral, such as 
prescriptions for spectacles or contact lenses, were col­
lected from clinical records of various ophthalmologists 
and institutions.
In all patients in this study, homocysteine and 
methionine concentrations in blood were up to about
20 times the normal upper limit of 19 |xmol/l, and the 
residual activity of cystathionine synthase in cultured 
fibroblasts was maximally 3% of the mean activity of 
normal subjects.U rine screening with the cyanide- 
nitroprusside test was used only in the first 16 patients; 
it was stopped because of false negative results in 38% 
and a borderline result in an additional 25% of the 
patients.
Results
In 34 consecutive patients in whom homocystinuria 
was detected (table 1) the mean age at diagnosis of 
homocystinuria was 24 (range 1-61) years. In only four 
(12%) of the 34 patients was the diagnosis of 
homocystinuria established before the age of 5 years. In
23 (68%) the diagnosis of this congenital metabolic 
disease was not made until adulthood (range 20-61 
years). The diagnosis had been frequently missed at 
previous examinations by clinicians of various disci­
plines. Despite repeated physical examinations, the 
interval between the first major signs of the disease (at a 
mean age of 13 (1-40) years) and diagnosis of 
homocystinuria was 11 (0-43) years.
Before the diagnosis was made, 30 (88%) patients 
already had one or more serious manifestations of 
homocystinuria. These included occlusion of peripheral 
arteries, pulmonary embolism, cerebrovascular acci­
dent, deep vein thrombosis in the leg, ectopia lentis, 
acute pupil block glaucoma, scoliosis, marfanoid 
features, mental retardation, epilepsy, and psychosis. 
Only the four (12%) patients who were diagnosed by
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Table 1—Manifestations of homocystinuria in 34 consecutive patients
Patient First major signs of the disease; Age at diagnosis of Condition leading to diagnosis of
No Sex age (years) ectopia, lentis homocystinuria; age (years)
1 F High myopia, psychosis, pulmonary embolisms; 49 History of ectopia lentis; age 50
age 40
Acute glaucoma and history of ectopia lentis; 
age 20
2 F High myopia, ectopia lentis, mental retardation; 
age 5
5
3 F Very high myopia and ectopia lentis; age 4 4 History of ectopia lentis; age 20
4 M Myopia and sister with ectopia lentis Screening of siblings of patient 3; age 25
(patient 3); age 9
Crural thrombosis and ectopia lentis; age 275 M Myopia and seizures; age 4 26
6 F
W p
Very high myopia; age 18 19 Acute glaucoma, ectopia lentis, arterial
ischaemia; age 21
7 F High myopia and carotid artery stenosis; Screening of siblings of patient 6; age 29
age 26
Cerebrovascular accident and ectopia lentis; 
age 22
8 M High myopia, marfanold features, mental 
retardation; age 8
16
9 F Very high myopia and marfanold features; 
age 14
17 Acute glaucoma, ectopia lentis, 
cerebrovascular accident; age 20
10 M Very high myopia and ectopia lentis; age 4 4 Ectopia lentis; age 4
11 M Brother with ectopia lentis (patient 10); age 3 Screening of siblings of patient 10; age 3
12 p Myopia and crural thrombosis; age 21 36 Retinal detachment after ectopia ientis; age 53
13 p High myopia, psychosis, cardiac ischaemia; 50 Screening of siblings of patient 12; age 50
age 24
History of ectopia lentis; age 3114 F High myopia in childhood; age 4 7
15 M Myopia and psychomotor retardation; age 1 1 Surgery for marfanoid features; age 15
16 M Myopia and marfanoid features; age 6 10 Acute glaucoma; age 11
17 M High myopia and marfanoid features; age 6 6 History of ectopia lentis; age 23
18 F Psychomotor retardation and marfanoid 
features; age 7
Marfanoid and mental features; age 9
19 F Very high myopia; age 22 23 Fetal loss, thrombosis, psychosis; age 46
20 M Myopia, psychomotor retardation, seizures; 
age 3
6 Acute glaucoma, crural thrombosis; age 9
21 M High myopia and marfanoid features; age 6 13 History of ectopia lentis and marfanoid signs;
age 29
22 M High myopia and marfanoid features; age 6 10 History of ectopia lentis and marfanoid signs;
age 26
23 F Myopia and pulmonary embolism; age 18 25 High myopia and ectopia lentis; age 25
24 F Myopia and psychomotor retardation; age 5 6 History of ectopia lentis; age 7
25 M Sister with ectopia lentis (patient 23); age 20 Screening of siblings of patient 23; age 20
26 p High myopia and surgery for scoliosis; age 18 49 History of ectopia lentis and pulmonary
thrombosis; age 61
27 F High myopia and ectopia lentis; age 17 17 History of ectopia lentis; age 19
28 M Myopia, ectopia lentis, psychomotor 
retardation; age 3
3 Ectopia lentis; age 3
29 M Very high myopia; age 30 Very high myopia; age 30
30 M High myopia and psychomotor retardation; 
age 5
8 Very high myopia and ectopia lentis; age 8
31 M Cerebrovascular accident; age 1 Cerebrovascular accident; age 1
32 p Very high myopia; age 21 31 Cerebrovascular accident; age 31
33 M Sister with ectopia lentis (patient 32); age 23 Screening of siblings of patient 32; age 23
34 M Myopia and ectopia lentis; age 35 35 History of ectopia lentis and cardiac infarctions; 
age 52
Myopia = myopia £1 dioptre; high myopia -  myopia ^5 dioptres; very high myopia: myopia s*
i
10 dioptres.
the screening of siblings for homocystinuria had had no lentis, thereby causing significant >stic
complications. (mean 8(0-24) years) in these 26 patients.
Ectopia lends, though diagnosed in 26 (76%) of the 34 Although most of the patients had no unusual refractive 
homocystinuria patients at a mean age of 18 (1-50) errors in early childhood, myopia seemed to be the most
years, did not lead to adequate biochemical analysis for consistent initial finding in homocystinuric
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Flfl 1 —Methionine metabolism in humans
homocystinuria at the time of detection of the ectopia patients before the first major complications occurred.
In 28 (93%) of the 30 patients with major compli­
cations, myopia of various degree (&1.0 dioptre) had 
been documented in prescriptions for spectacles or 
contact lenses before the time that their first complica­
tions occurred. When systemic complications occurred 
in these patients, we defined such condition as “myopia 
plus”: myopia (>1.0 dioptre) associated with signs of 
systemic disease (that is, complications of homo­
cystinuria): myopia plus vascular events, myopia 
skeletal abnormalities, or myopia plus central nervous 
system involvement. Myopia plus was present in 24 
(71%) patients. Unusually high myopia (25*5.0 dioptres) 
was present in 24 (71%) patients at the time of diag­
nosis of homocystinuria; of these, 16 (47%) had very 
high myopia (>10.0 dioptres). Only two (6%) patients, 
a 7 year old girl (patient 18) and a 1 year old boy 
(patient 31), had systemic complications of homo­
cystinuria with absence of myopia. Three patients (cases 
11, 18, and 31) were diagnosed very early as having
Homocysteine
Pyridoxal
phosphate Homocysteine- 
cysteine- 
mixed disulphide
1038 BMJ v o lu m e  313 26 ocrroBRR 1996
homocystinuria and started pyridoxine treatment 
before myopia developed; they had no myopia or 
ectopia lentis in follow up periods of 26, 14s and 5 years 
respectively. The diagnosis of ectopia lentis was 
preceded by detection of myopia in all cases.
In most patients there was more than one cause for 
diagnostic delay. The major causes were, firstly, not rec-
»WnrwWMM-*«
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• The diagnosis of homocystinuria is often missed
• High myopia may be caused by ectopia lentis
• Unusual myopia combined with skeletal, vascu­
lar, or central nervous system manifestations may 
have its origin in homocystinuria
• Patients with ectopia lentis should have appro­
priate blood examinations for homocystinuria
ogmsing that myopia, although unusual in presentation 
(early, high, very high, or abnormal progressive) was of 
lenticular origin—that is, the result of subluxation of the 
lenses (24 patients); secondly, not considering a 
common cause for the various organ complications and 
the unusual myopia (myopia plus; 21 patients); thirdly,
not performing biochemical investigations for homo- undiagnosed homocystinuria, or their parents, may be 
cystinuria in patients with ectopia lentis because the very anxious about the progression of the myopia. They 
ectopia lentis was thought to be a purely ocular disorder may erroneously be advised to undergo surgical 
or attributed to Marian’s syndrome (20 patients); and, treatment of the refraction anomaly by radial 
fourthly, not screening the family after ectopia lentis or keratotomy or excimer laser keratectomy, instead of 
homocystinuria, or both were diagnosed (four patients), receiving treatment for the cause of myopia. Apart from 
Thirty one patients (91 %) responded completely or this, an important concern should be that many compli- 
partially to vitamin B6. Patient 15 was a non-responder cations at a young age in clearly myopic patients, such as 
and in two patients response was unknown (patient 9 pulmonary embolism, cerebrovascular accident, exces- 
died some days after diagnosis and patient 16 was lost to sive height, seizures, or mental retardation, do not
follow up).
Discussion
From 34 consecutive patients diagnosed as having
always lead to the diagnosis of a causal systemic disea.se. 
It is apparent from our study that the association of any 
of these complications with myopia, which we have 
called myopia plus, is a valuable clue to the diagnosis of
homocystinuria. Several case reports confirm this
«-12homozygous homocystinuria it is clear that the diag- statement, 
nosis is often missed even when characteristic clinical 
signs and complications are present. Serious clinical 
sequelae such as life threatening thromboembolic 
events at a young age, mental retardation, and ectopia 
lentis might be prevented by prompt treatment of
patients detected as having homocystinuria. High date of detection of ectopia lentis rather than of its 
doses of vitamin B6 (pyridoxine), which is a cofactor of acmal occurrence. in homocystinuria the age of
ECTOPIA LENTIS
Ectopia lentis occurs in about 85% of homo­
cystinuria patients.211 14 As correctly noted by Mudd 
and associates,2 data on age of lens dislocation represent
the deficient enzyme cystathionine synthase, decreases 
the effects of the disease. Patients who do not respond 
to vitamin B6 can be treated by folic acid and betaine,
development of high myopia (>5 dioptres) before the 
detection of ectopia lentis is a better indication of the 
start of lens dislocation. Even when ectopia lentis is
which are both substrates for the remethylation of established it unfortunately does not lead to the correct
«  I  i l l  4  «  I  «  *  ft V
diagnosis because biochemical investigation is not done.homocysteine to methionine, or by dietary methionine 
restriction.1 It is obvious diat early diagnosis is crucial 
for the prognosis of these patients.2 However, in most of disease
These patients are not suspected of having a systemic
as having Marfan’sor are
our 34 patients homocystinuria was not suspected for a
long time, although indications for the diagnosis were features. The 
clearly present. The mean age of diagnosis in these 
patients was 24 years. Though they had had many
ophthalmological examinations there was a diagnostic cystinuria was described,several papers dealing with
delay between the appearance of the first ocular symp- Marfan’s syndrome either included cases of homo­
toms, such as unusual myopia and ectopia lentis, and
the ultimate biochemical diagnosis of homocystinuria.
syndrome because of the presence of marfanoid
importance of differentiating homo­
cystinuria from Marfan’s syndrome has been pointed 
out previously.1'’'17 Even after 1962, when homo-
IH-t'l
UNUSUAL MYOPIA
cystinuria or did not provide sufficient evidence that 
homocystinuria had been excluded.2“ Furthermore, in 
cases in which ophthalmologists are aware of the neces­
sity to exclude homocystinuria, the correct diagnosis 
It is understandable that the development of moder- can be missed due to inadequate biochemical investiga- 
ate myopia in the second decade of life causes little sus- tion. The urinary cyanide-nitroprusside test (Brand
test), the screening test recommended by many 
authors,1“ *MI has a fairly high false negative rate in 
homocystinuria patients, particularly in newborns and
,112 and can give false positive
picion that there is a metabolic disease because myopia 
is a common finding in the normal population.
However, myopia in excess of 5 dioptres is extremely 
rare in children under 5 years0 and probably affects mildly affected
anunder 2% of adults,7 In such high myopia, 
abnormality of one particular component of ocular
results in many normal subjects. The modification of
the test by Spaeth as the
refraction of die axial length, the corneal curvature, or silver-nicroprusside test, which excludes the detection of 
the lens is most likely.*1 Thus, if the ocular fundus of a
highly myopic patient shows no clear ophthalmoscopic enhance the sensitivity as
cystinuria, may enhance the specificity, but it does not
Uauthors
signs of axial myopia and the corneal curvature is not 
abnormal, then lenticular myopia due to ectopia lentis
Homocysteine concentration (preferably measured as 
total plasma homocysteine1'1) and methionine concen-
should be suspected and searched for. If subluxation of tration in plasma should be determined, and
the lens is suspected, but not visible, the presence of an measurement of cystathionine synthase activity in
abnormal lens power can be concluded from calculation cultured fibroblasts from a skin biopsy should confirm
of the dioptric power of the intraocular lens from refrac- the diagnosis enzymatically.
tion, keratometry, and length measurements. In summary, the finding of “unusual” myopia.high
Other clues for lenticular myopia are abnormally rapid myopia, very high myopia, abnormal progressive
progression of myopia, high myopia in children, myopia, myopia at young age, or high myopia without
progressive myopia in adult life, and high non-comeal myopic fundus-..should warrant the ophthalmologist to
astigmatism with subnormal visual acuity. Patients with search carefully for ectopia lentis. If ectopia lentis can be
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established, adequate biochemical investigations for 
homocystinuria are mandatory. The recognition of 
myopia in patients with thromboembolism, skeletal
or central nervous system complications 
should alert physicians to the possibility that "myopia 
plus” can have its origin in homocystinuria.
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Insulin sensitivity and. regular alcohol consumption: large, 
prospective, cross sectional population study (Bruneck study)
Stefan Kiechl, Johann Willeit, Werner Poewe, Georg Egger, Friedrich Oberhollenzer, 
Michele Muggeo, Enzo Bonora
Abstract
Objectives—To assess the relation between 
regular alcohol consumption and insulin sensitiv­
ity, and to estimate the importance of insulin in 
the association of alcohol with multiple vascular 
risk factors and cardiovascular disease.
Design—-"Prospective and cross sectional study 
of a large randomly selected population sample.
Setting—Part of the Bruneck study 1990-5 (Bol­
zano province, Italy).
Subjects—820 healthy non-diabetic women and 
men aged 40-79 years.
Main outcome measure—Concentrations of 
fasting and post-glucose insulin, cholesterol, 
apolipoproteins, triglycerides, Lp(a) lipoprotein, 
glucose, fibrinogen, and antithrombin III; blood 
pressure; insulin resistance estimated by the 
homeostasis model assessment.
Results—Fasting insulin concentrations in 
those who did not drink alcohol and subjects 
reporting low (1-50 g/day), moderate (51-99 
g/day), and heavy (>100 g/day) alcohol intake were 
12.4, 10.0, 8.7, and 7.1 mU/1 (P<0.001). Likewise, 
post-glucose insulin concentrations and estimates 
for insulin resistance assessed by the homeostasis 
model assessment decreased significantly with in­
creasing amounts of regular alcohol consumption. 
These trends were independent of sex, body mass 
index, physical activity, cigarette smoking,
medication, and diet (P<0.001). Regular alcohol 
intake predicted multiple changes in vascular risk 
factors over a five year period including increased 
concentrations of high density lipoprotein 
cholesterol and apolipoprotein A I; higher blood 
pressure; and decreased concentration of anti­
thrombin III. These associations were in part 
attributable to the decrease in insulin concentra­
tions observed among alcohol consumers.
Conclusions—Low to moderate amounts of 
alcohol, when taken on a regular basis, improve 
insulin sensitivity. Insulin is a potential interme­
diate component in the association between 
alcohol consumption and vascular risk factors 
(metabolic syndrome).
Introduction
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